CANC

Tema Oncology ETF

Feb 05 • 04:00PM ET

35.57

-0.87 -2.39 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	44.21%	Total Holdings	57	Perf Week	-1.44%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	150.44M	Perf Month	2.91%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	16.87%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	37.51 -5.17%	Perf Half Y	37.68%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 77.00%	Perf YTD	2.45%
Active/Passive		Quant Type		Tags	-	Flows% 1M	22.36%	Volatility	2.13% 2.09%	Perf Year	40.54%
Dividend TTM	0.02 (0.06%)	ESG Type		Tags	-	Flows% 3M	45.86%	ATR (14)	0.74	Perf 3Y	-
Dividend Ex-Date	Dec 10, 2025	Dividend Type		Sector/Theme		Flows% YTD	24.10%	RSI (14)	46.51	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.95	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	-2.31%	Flows% 3Y		Rel Volume	0.31	Prev Close	36.44
Inverse/Leveraged		Market Cap		SMA50	0.05%	Flows% 5Y		Avg Volume	37.67K	Price	35.57
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	22.05%	Trades		Volume	11,761	Change	-2.39%

Jan-09-26 10:00AM	Here's Why Biotech ETFs Are Rallying Hard (Zacks)
Dec-02-25 06:00AM	Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance (Business Wire)
Nov-26-25 10:00AM	Be Thankful to These ETFs This Year (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience